デフォルト表紙
市場調査レポート
商品コード
1750793

眼科におけるAI市場規模、シェア、動向分析レポート:用途別、展開モード別、技術別、最終用途別、地域別、セグメント別予測、2025年~2030年

AI In Ophthalmology Market Size, Share & Trends Analysis Report By Application (Disease Detection & Monitoring, Surgical Planning & Outcome Prediction), By Deployment Mode, By Technolog, By End-use, By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 120 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
眼科におけるAI市場規模、シェア、動向分析レポート:用途別、展開モード別、技術別、最終用途別、地域別、セグメント別予測、2025年~2030年
出版日: 2025年05月30日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

眼科におけるAI市場概要

眼科におけるAIの世界市場規模は、2024年に2億923万米ドルと推定され、2025~2030年にかけて36.79%のCAGRで成長し、2030年には13億6,000万米ドルに達すると予測されています。眼病有病率の上昇、画像技術の進歩、遠隔眼科サービスの拡大が市場成長の要因です。

加えて、個別化された治療計画への嗜好の高まりや政府のイニシアチブの増加が市場成長をさらに後押ししています。糖尿病性網膜症、加齢黄斑変性(AMD)、緑内障など、眼に関連する疾患の有病率の増加は、眼科におけるAIの採用を促進する重要な要因です。人口の高齢化に伴い、これらの疾患の発生率は増加し、効率的で正確な診断ツールの必要性が生じています。例えば、CDCによると、2022年に緑内障を患う米国人の推定数は422万人です。AIアルゴリズムは、複雑な網膜画像を迅速に分析し、早期発見と治療を促進することができます。例えば、AIシステムは糖尿病性網膜症の特定において高い感度と特異性を示しており、タイムリーな介入を可能にし、視力低下のリスクを低減します。

さらに、光干渉断層計(OCT)のような先進的画像技術をAIと統合することで、眼科診断に革命をもたらしました。高解像度画像は眼構造の詳細なビューを提供し、人工知能(AI)で分析することで診断精度を高めます。このような画像技術から得られる大規模なデータセットを利用することで、ロバストなAIモデルのトレーニングが可能になり、臨床現場での精度と信頼性が向上します。例えば、香港中文大学(CUHK)の研究者は、先進的AI眼科画像基盤モデルであるVisionFMを開発しました。8つのモダリティにわたる340万枚の画像で訓練されたVisionFMは、複数の眼疾患を診断し、網膜画像から頭蓋内腫瘍を独自に予測します。

さらに、眼科医療サービスの遠隔提供である遠隔眼科医療は、特に十分なサービスを受けていない地域で支持を集めています。AIは網膜画像の自動分析を可能にし、遠隔診断を容易にし、対面診察の必要性を減らすことで、この拡大において極めて重要です。このアプローチは、眼科医療へのアクセスを向上させ、ヘルスケアシステムにおける資源利用を最適化します。例えば、2024年6月、眼科医療技術の新興企業であるC3 Med-Techは、AI対応のポータブル眼科検診機器を発売するため、23万米ドルを調達しました。この資金調達は、遠隔医療の統合、リアルタイムの疾患検出、インド全土への拡大をサポートし、特に眼科医不足に直面している恵まれないコミュニティで、回避可能な失明を減らすことを目指すと期待されています。

さらに、電子カルテ(EHR)からのデータを分析・解釈するAIの能力は、眼科における個別化された治療計画を促進します。AIは患者の病歴、遺伝情報、画像データを評価することで病気の進行を予測し、オーダーメイドの介入を推奨するため、市場の成長にさらに貢献します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 眼科におけるAI市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助的な市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 使用事例
  • 眼科市場分析ツールにおけるAI
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 眼科におけるAI市場:用途別、推定・動向分析

  • セグメントダッシュボード
  • 眼科におけるAI市場の世界用途変動分析
  • 眼科におけるAIの世界市場規模と動向分析(用途別、2018~2030年)
  • 病気の検出とモニタリング
    • 網膜疾患の検出
    • 緑内障の検出とモニタリング
  • 手術計画と結果予測
  • 眼科画像診断ワークフロー自動化のためのAI
  • その他

第5章 眼科におけるAI市場:展開モード、推定・動向分析

  • セグメントダッシュボード
  • 眼科におけるAI市場の展開モード変動分析
  • 眼科におけるAIの世界市場規模と動向分析(展開モード別、2018~2030年)
  • オンプレミス
  • クラウドベース

第6章 眼科におけるAI市場:技術別、推定・動向分析

  • セグメントダッシュボード
  • 眼科におけるAI市場の技術変動分析
  • 眼科におけるAIの世界市場規模と動向分析(技術別、2018~2030年)
  • 機械学習
    • ディープラーニング
    • 監督付き
    • 監督なし
    • その他
  • 自然言語処理
    • 臨床文書作成支援
    • OCR(光学文字認識)
    • 眼科ノートの自動コーディング
    • 診断推論のためのテキスト分析
    • 音声ベースの診断記録(音声テキスト変換)
  • コンテキストアウェアコンピューティング
  • コンピュータービジョン

第7章 眼科におけるAI市場:最終用途別、推定・動向分析

  • セグメントダッシュボード
  • 眼科におけるAI市場の最終用途変動分析
  • 眼科におけるAIの世界市場規模と動向分析(最終用途別、2018~2030年)
  • 病院
  • 専門眼科クリニック
  • 学術研究機関
  • 支払者と保険会社
  • その他

第8章 眼科におけるAI市場:地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模と予測動向分析、2018~2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2024年
  • 企業プロファイル/上場企業
    • OphtAI
    • Eyenuk, Inc.
    • Google LLC
    • IBM Corporation
    • Optos plc
    • Zeiss
    • Topcon Healthcare
    • Ikerian AG(RetinAi)
    • Nidek Co., Ltd.
    • Altris AI
    • Remidio Innovative Solutions Pvt Ltd.
    • Oculus Maxima LIMITED
    • Siemens Healthineers
    • Haag-Streit Group
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global AI in ophthalmology market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 5 Global AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 6 Global AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America AI in ophthalmology market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 10 North America AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 11 North America AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 12 U.S. AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 14 U.S. AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 15 U.S. AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Canada AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 17 Canada AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 18 Canada AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Canada AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Mexico AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 21 Mexico AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 22 Mexico AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 23 Mexico AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Europe AI in ophthalmology market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 26 Europe AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 27 Europe AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Europe AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 29 UK AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 30 UK AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 31 UK AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 32 UK AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Germany AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 34 Germany AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 35 Germany AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Germany AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 37 France AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 38 France AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 39 France AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 40 France AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Italy AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 42 Italy AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 43 Italy AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Italy AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Spain AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 46 Spain AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 47 Spain AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Spain AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Denmark AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 50 Denmark AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 51 Denmark AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Denmark AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Sweden AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 54 Sweden AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 55 Sweden AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Sweden AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Norway AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 58 Norway AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 59 Norway AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 60 Norway AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific AI in ophthalmology market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 66 China AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 67 China AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 68 China AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 69 China AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Japan AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 71 Japan AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 72 Japan AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Japan AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 74 India AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 75 India AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 76 India AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 77 South Korea AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 78 South Korea AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 79 South Korea AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 80 South Korea AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Australia AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 82 Australia AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 83 Australia AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Australia AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Thailand AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 86 Thailand AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 87 Thailand AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Thailand AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Latin America AI in ophthalmology market, by country, 2018 - 2030 (USD Million)
  • Table 90 Latin America AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 91 Latin America AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 92 Latin America AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 93 Latin America AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Brazil AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 95 Brazil AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 96 Brazil AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 97 Brazil AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 98 Argentina AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 99 Argentina AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 100 Argentina AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Argentina AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 102 MEA AI in ophthalmology market, by country, 2018 - 2030 (USD Million)
  • Table 103 MEA AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 104 MEA AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 105 MEA AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 106 MEA AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 107 South Africa AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 108 South Africa AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 109 South Africa AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 110 South Africa AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 115 UAE AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 116 UAE AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 117 UAE AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 118 UAE AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)
  • Table 119 Kuwait AI in ophthalmology market, by application, 2018 - 2030 (USD Million)
  • Table 120 Kuwait AI in ophthalmology market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 121 Kuwait AI in ophthalmology market, by technology, 2018 - 2030 (USD Million)
  • Table 122 Kuwait AI in ophthalmology market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Market formulation & validation
  • Fig. 5 AI in Ophthalmology market: Market outlook
  • Fig. 6 AI in Ophthalmology market: Segment outlook
  • Fig. 7 AI in Ophthalmology market: Competitive landscape outlook
  • Fig. 8 Parent market outlook
  • Fig. 9 AI in ophthalmology market driver impact
  • Fig. 10 AI in ophthalmology market restraint impact
  • Fig. 11 AI in ophthalmology market: Application outlook and key takeaways
  • Fig. 12 AI in ophthalmology market: Application movement analysis
  • Fig. 13 Disease detection and monitoring market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 14 Retinal disease detection market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Diabetic retinopathy market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 16 Diabetic macular edema market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Age-related macular degeneration market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 18 Retinal vein occlusion market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Glaucoma detection & monitoring market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 20 Surgical planning & outcome prediction market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 AI for ophthalmic imaging workflow automation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 AI in ophthalmology market: Deployment mode outlook and key takeaways
  • Fig. 24 AI in ophthalmology market: Deployment mode movement analysis
  • Fig. 25 On premise market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 26 Cloud-based market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 AI in ophthalmology market: Technology outlook and key takeaways
  • Fig. 28 AI in ophthalmology market: Technology movement analysis
  • Fig. 29 Machine learning market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 30 Deep learning market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Supervised market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 32 Unsupervised market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 34 Natural language processing market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 35 Clinical documentation assistance market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 36 Optical character recognition (OCR) market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Auto-coding of ophthalmology notes market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 38 Text analytics for diagnostic reasoning market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 39 Voice-based diagnostic recording (speech-to-text) market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 40 Context-aware computing market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 41 Computer vision market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 42 AI in ophthalmology market: End use outlook and key takeaways
  • Fig. 43 AI in ophthalmology market: End use movement analysis
  • Fig. 44 Hospitals market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 45 Specialty ophthalmology clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Academic & research institutions market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 47 Payers and insurance firms market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 48 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Global AI in ophthalmology market: Regional outlook and key takeaways
  • Fig. 50 Global AI in ophthalmology market: Regional movement analysis
  • Fig. 51 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. key country dynamics
  • Fig. 53 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Canada key country dynamics
  • Fig. 55 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico key country dynamics
  • Fig. 57 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 UK key country dynamics
  • Fig. 60 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Germany key country dynamics
  • Fig. 62 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 France key country dynamics
  • Fig. 64 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Italy key country dynamics
  • Fig. 66 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Spain key country dynamics
  • Fig. 68 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Denmark key country dynamics
  • Fig. 70 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Sweden key country dynamics
  • Fig. 72 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Norway key country dynamics
  • Fig. 74 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Japan key country dynamics
  • Fig. 77 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 China key country dynamics
  • Fig. 79 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 India key country dynamics
  • Fig. 81 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Thailand key country dynamics
  • Fig. 83 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 South Korea key country dynamics
  • Fig. 85 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Australia key country dynamics
  • Fig. 87 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Brazil key country dynamics
  • Fig. 90 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Argentina key country dynamics
  • Fig. 92 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 South Africa key country dynamics
  • Fig. 95 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Saudi Arabia key country dynamics
  • Fig. 97 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 UAE key country dynamics
  • Fig. 99 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Kuwait key country dynamics
  • Fig. 101 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-598-7

AI In Ophthalmology Market Summary

The global AI in ophthalmology market size was estimated at USD 209.23 million in 2024 and is projected to reach USD 1.36 billion by 2030, growing at a CAGR of 36.79% from 2025 to 2030. The rising prevalence of eye diseases, advancements in imaging technology, and expansion of teleophthalmology services are factors contributing to market growth.

In addition, growing preference for personalized treatment plans and increasing government initiatives fuel market growth further. The increasing prevalence of eye-related conditions, such as diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma, is a significant factor driving the adoption of AI in ophthalmology. As the population ages, the incidence of these diseases increases, creating a need for efficient and accurate diagnostic tools. For instance, according to the CDC, the estimated number of Americans living with glaucoma in 2022 was 4.22 million. AI algorithms can rapidly analyze complex retinal images, facilitating early detection and treatment. For instance, AI systems have shown high sensitivity and specificity in identifying diabetic retinopathy, which allows for timely interventions and reduces the risk of vision loss.

Moreover, integrating advanced imaging techniques such as Optical Coherence Tomography (OCT) with AI has revolutionized ophthalmic diagnostics. High-resolution imaging provides detailed views of ocular structures, which enhances diagnostic precision when analyzed by artificial intelligence (AI). The availability of large datasets from these imaging technologies allows for the training of robust AI models, improving their accuracy and reliability in clinical settings. For instance, researchers at the Chinese University of Hong Kong (CUHK) have developed VisionFM, an advanced AI ophthalmic imaging foundation model. Trained on 3.4 million images across eight modalities, VisionFM diagnoses multiple eye diseases and uniquely predicts intracranial tumors from retinal images.

Furthermore, teleophthalmology, the remote delivery of eye care services, has gained traction, especially in underserved regions. AI is crucial in this expansion by enabling automated analysis of retinal images, facilitating remote diagnosis, and reducing the need for in-person consultations. This approach increases access to eye care and optimizes resource utilization in healthcare systems. For instance, in June 2024, C3 Med-Tech, an ophthalmic health tech startup, raised USD 0.23 million to launch AI-enabled, portable eye screening devices. The funding is expected to support telemedicine integration, real-time disease detection, and expansion across India, aiming to reduce avoidable blindness, especially in underserved communities facing a shortage of ophthalmologists.

Moreover, AI's ability to analyze and interpret data from Electronic Health Records (EHRs) facilitates personalized treatment plans in ophthalmology. AI predicts disease progression by assessing patient history, genetic information, and imaging data and recommends tailored interventions, further contributing to market growth.

Global AI In Ophthalmology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global AI in ophthalmology market report based on application, deployment mode, technology, end-use, and region.

  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Disease Detection and Monitoring
    • Retinal Disease Detection
    • Diabetic Retinopathy (DR)
    • Diabetic Macular Edema (DME)
    • Age-related Macular Degeneration (AMD)
    • Retinal Vein Occlusion (RVO)
    • Glaucoma Detection & Monitoring
  • Surgical Planning & Outcome Prediction
  • AI for Ophthalmic Imaging Workflow Automation
  • Others
  • Deployment Mode Outlook (Revenue, USD Million, 2018 - 2030)
  • On Premise
  • Cloud-based
  • Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • Machine Learning
    • Deep learning
    • Supervised
    • Unsupervised
    • Others
  • Natural Language Processing
    • Clinical Documentation Assistance
    • OCR (Optical Character Recognition)
    • Auto-coding of Ophthalmology Notes
    • Text Analytics for Diagnostic Reasoning
    • Voice-based Diagnostic Recording (Speech-to-Text)
  • Context-Aware Computing
  • Computer Vision
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Specialty Ophthalmology Clinics
  • Academic & Research Institutions
  • Payers & Insurance Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Application Segment
    • 1.2.2. Deployment Mode Segment
    • 1.2.3. Technology Segment
    • 1.2.4. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. AI in Ophthalmology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of eye diseases and diabetes
      • 3.2.1.2. Advancements in imaging technology
      • 3.2.1.3. Expansion of teleophthalmology services
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Data security and privacy concerns
      • 3.2.2.2. High integration costs
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Case Studies
  • 3.4. AI in Ophthalmology Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape
      • 3.4.2.6. Social Landscape

Chapter 4. AI in Ophthalmology Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global AI in Ophthalmology Market Application Movement Analysis
  • 4.3. Global AI in Ophthalmology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Disease Detection and Monitoring
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Retinal Disease Detection
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Diabetic Retinopathy (DR)
        • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Diabetic Macular Edema (DME)
        • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Age-related Macular Degeneration (AMD)
        • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.5. Retinal Vein Occlusion (RVO)
        • 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Glaucoma Detection & Monitoring
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Surgical Planning & Outcome Prediction
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. AI for Ophthalmic Imaging Workflow Automation
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. AI in Ophthalmology Market: Deployment Mode Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global AI in Ophthalmology Market Deployment Mode Movement Analysis
  • 5.3. Global AI in Ophthalmology Market Size & Trend Analysis, by Deployment Mode, 2018 to 2030 (USD Million)
  • 5.4. On Premise
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Cloud-based
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. AI in Ophthalmology Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global AI in Ophthalmology Market Technology Movement Analysis
  • 6.3. Global AI in Ophthalmology Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 6.4. Machine Learning
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Deep learning
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Supervised
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Unsupervised
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Natural Language Processing
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Clinical Documentation Assistance
      • 6.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. OCR (Optical Character Recognition)
      • 6.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Auto-coding of Ophthalmology Notes
      • 6.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Text Analytics for diagnostic reasoning
      • 6.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Voice-based Diagnostic Recording (Speech-to-Text)
      • 6.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Context-Aware Computing
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Computer Vision
    • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. AI in Ophthalmology Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global AI in Ophthalmology Market End Use Movement Analysis
  • 7.3. Global AI in Ophthalmology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Specialty Ophthalmology Clinics
    • 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Academic & Research Institutions
    • 7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Payers and Insurance Firms
    • 7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. AI in Ophthalmology Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. OphtAI
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Technology type benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Eyenuk, Inc.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Technology type benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Google LLC
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Technology type benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. IBM Corporation
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Technology type benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Optos plc
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Technology type benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Zeiss
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Technology type benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Topcon Healthcare
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Technology type benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Ikerian AG (RetinAi)
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Technology type benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Nidek Co., Ltd.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Technology type benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Altris AI
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Technology type benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Remidio Innovative Solutions Pvt Ltd.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Technology type benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Oculus Maxima LIMITED
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Technology type benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Siemens Healthineers
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Technology type benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Haag-Streit Group
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Technology type benchmarking
      • 9.4.14.4. Strategic initiatives